suck pdf from google scholar
unlimited free pdf from europmc17476346    free
PDF from PMC    free
html from PMC    free
PDF vom PMID17476346 :   free
PDF vom PMID17476346
suck pdf from library genesis
English Wikipedia

Nephropedia Template TP (

Twit Text


  • DeepDyve
  • Pubget Overpricing


  • lüll
  • Tregs and rethinking cancer immunotherapy
  • Curiel TJ
  • J Clin Invest 2007[May]; 117 (5): 1167-74
  • Tumors express antigens that should induce immune-mediated rejection, but spontaneous rejection of established tumors is rare. Recent work demonstrates that one reason for the lack of tumor rejection is that tumors actively defeat host immunity. This concept forces us to rethink current approaches to harnessing potent, specific host immunity to battle cancer, most of which are based on the paradigm that inducing more antitumor immune cells alone is therapeutic. However, as I discuss in this Personal Perspective, a newer paradigm predicts that reducing tumor-driven immune suppression will be clinically beneficial. CD4+CD25+ Tregs are one mechanism of tumor-driven immune evasion that provide prototypical targets for testing novel anticancer treatment strategies within the newer paradigm.
  • |Animals[MESH]
  • |Humans[MESH]
  • |Immunotherapy/*methods/trends[MESH]
  • |Neoplasms/*immunology/metabolism/pathology/*therapy[MESH]
  • |T-Lymphocytes, Regulatory/cytology/*immunology/metabolism[MESH]





  • *{{pmid17476346}}
    *<b>[http://www.kidney.de/mlpefetch.php?search=17476346 Tregs and rethinking cancer immunotherapy ]</b> J Clin Invest 2007; 117(5) ; 1167-74 Curiel TJ

        *17476346*

    Nephropedia PMID record

    Deutsche Wikipedia - im Artikel

    Hier den unten stehenden Textblock hineinkopieren

    J Clin Invest

    1167 5.117 2007